Potassium Ion

Potassium Ion

SCHEMBL8056549

O=C([O-])Cn1nnnc1S.O=C([O-])Cn1nnnc1S.[K+].[K+]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
CYP1A2 P05177 1/20 0.31
KDM4C Q9H3R0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11228534 0.96 MAPK1 (0.35) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL631249 0.96 MAPK1 (0.35) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL10831559 0.81 ALDH1A1 (0.38) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL829258 0.80 ALDH1A1 (0.47) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL8056548 0.78 ALDH1A1 (0.46) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL7764233 0.78 MAPK1 (0.36) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL7764225 0.78 MAPK1 (0.36) MAPK1ALDH1A1HPGDCYP1A2KDM4C
SCHEMBL10831333 0.78 MAPK1 (0.40) MAPK1ALDH1A1HPGD
SCHEMBL11356709 0.75 CA1 (0.34) CYP1A2
SCHEMBL10401972 0.74 MAPK1 (0.40) MAPK1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150351-A ADMINISTERING AN EFFECTIVE AMOUNT OF THE CEPHEM COMPOUND TO A PATIENT SUFFERING FROM DISEASES CAUSED BY HELICOBACTER PYLORI FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-21 US disclosed
EP-0882052-A1 NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed
WO-1997029111-A1 NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-14 WO disclosed